What is ClickDiagnostics?
ClickDiagnostics is a pioneering health-tech company established in May 2008, dedicated to leveraging mobile phone technology to address critical healthcare challenges. The company brings together a multidisciplinary team of technologists, medical professionals, and public health experts to create innovative mobile-based health services. ClickDiagnostics' core premise is to utilize the ubiquity of mobile phones to connect patients with medical professionals for remote diagnosis and consultation, particularly in regions with limited access to healthcare. Their platform facilitates real-time health data collection and analysis, enabling effective health interventions and improving patient outcomes. The company has been actively implementing its mobile tele-consultation services across Africa, South Asia, and the Americas, demonstrating a commitment to expanding healthcare accessibility globally.
How much funding has ClickDiagnostics raised?
ClickDiagnostics has raised a total of $196.3M across 4 funding rounds:
Series A
$16M
Debt
$9.5M
Series B
$100.8M
Series C
$70M
Series A (2015): $16M, investors not publicly disclosed
Debt (2018): $9.5M, investors not publicly disclosed
Series B (2020): $100.8M, investors not publicly disclosed
Series C (2020): $70M featuring Cedars-Sinai, John Doerr, and Pitango Venture Capital
Key Investors in ClickDiagnostics
Cedars-Sinai
Cedars-Sinai, a renowned non-profit academic medical center founded in 1902, offers a wide spectrum of clinical programs and is dedicated to improving community health, particularly for vulnerable populations.
Pitango Venture Capital
Pitango Venture Capital is a leading venture capital firm that supports visionary entrepreneurs and groundbreaking companies across various sectors, including HealthTech, with a focus on fostering innovation and growth from stealth mode to maturity.
John Doerr
John Doerr is a notable figure in the investment landscape, contributing to the growth and development of companies through strategic backing.
What's next for ClickDiagnostics?
With its recent major strategic investment and a history of significant capital raises, ClickDiagnostics is poised for accelerated growth and expansion. The company's focus on mobile-based tele-consultation and data collection positions it at the forefront of digital health innovation. Future developments are likely to involve further enhancement of its platform's analytical capabilities, broader geographic reach, and deeper integration with public health infrastructure. This strategic financing will undoubtedly fuel the company's efforts to scale its operations, develop new service offerings, and solidify its market position as a leader in accessible healthcare solutions.
See full ClickDiagnostics company page
